Beth Purdy

Beth Purdy has extensive experience in regulatory affairs within the biopharmaceutical industry, having held various leadership positions since 1993. Early roles include Reg CMC / Analytical Chemist at Mylan Laboratories Limited and Manager of Regulatory Affairs at Baker Norton Pharmaceuticals. Subsequent positions include Sr. Manager, Regulatory Affairs at Aspire Pharmaceuticals, and various roles at Novartis Pharmaceuticals Corporation, culminating in Associate Director, Regulatory CMC. Additional experience includes Associate Director at Progenics Pharmaceuticals, Director Global Regulatory CMC at Telix Pharmaceuticals Limited, and Senior Director roles at Seagen and Pfizer. Throughout her career, Purdy has focused on regulatory affairs for both developmental and marketed products, contributing significantly to the regulatory landscape of biopharmaceuticals.